Literature DB >> 3502129

[Evaluation of the desaturated Panel D-15. II: Comparison between the desaturated Panel D-15 and Farnsworth 100-hue tests].

P Lanthony1.   

Abstract

The color vision was examined in 319 subjects in a comparative manner by means of the desatured Panel D-15 and Farnsworth 100-hue test used as reference test. The results expressed by scoring, were as follows: 1) a strong correlation (r = 0.80) was evidenced between the 2 tests; 2) the probable scores of the desaturated Panel D-15 were predicted from the 100-hue scores, by means of a suitable regression equation; thus allowing the calculation of norms of the desaturated Panel D-15 by reference to the well-established norms according to age of the 100-hue test; 3) the normal or pathological character of the scores of the desaturated Panel D-15 was infered from these norms, and was in good agreement with the scores of 100-hue test (K = 0.68); 4) the normal or pathological character of the qualitative patterns of the desaturated Panel D-15 was also infered from the scores; so: the minor errors were normal from 30 years old patients; a single diametral error is normal; 3 or 4 diametral errors are normal from 65 years old patients.

Entities:  

Mesh:

Year:  1987        PMID: 3502129

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  3 in total

1.  Color vision and age in a normal North American population.

Authors:  M S Roy; M J Podgor; B Collier; R D Gunkel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

2.  Subclinical impairment of colour vision among workers exposed to styrene.

Authors:  A Muttray; D Jung; J Konietzko
Journal:  Br J Ind Med       Date:  1993-08

3.  Assessment of vision-related quality of life in patients with homonymous visual field defects.

Authors:  Eleni Papageorgiou; Gregor Hardiess; Frank Schaeffel; Horst Wiethoelter; Hans-Otto Karnath; Hanspeter Mallot; Birgitt Schoenfisch; Ulrich Schiefer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-25       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.